Zhi bai di huang wan
Food supplement declared in France, declaration No 2023-9-1134, decision dated 20 September 2023
Zhi bai di huang wan, from Calebasse, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Rehmannia glutinosa 0.9 g per day, Cornus officinalis 0.45 g per day, Dioscorea oppositifolia 0.45 g per day, Alisma plantago-aquatica 0.3 g per day, Paeonia × 0.3 g per day. 1 point in its composition requires a check (prohibited substance, dose or novel food). 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- Calebasse
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 3 g
- Directions for use
- 3g soit 6 gélules
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Heart problems, Liver problems, Taking anticoagulants, Taking diabetes medication, Taking medication
Declaration 312510, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Rehmannia glutinosa (Gaertn.) DC. | Racine | Extrait sec aqueux | 0.9 g |
| Cornus officinalis Siebold & Zucc. | Fruit | Extrait sec aqueux | 0.45 g |
| Dioscorea oppositifolia L. | Rhizome | Extrait sec aqueux | 0.45 g |
| Alisma plantago-aquatica L. | Rhizome | Extrait sec aqueux | 0.3 g |
| Paeonia × suffruticosa Andrews | Ecorce | Extrait sec aqueux | 0.3 g |
| Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb. | Sclérote | Extrait sec aqueux | 0.3 g |
| Anemarrhena asphodeloides Bunge | Rhizome | Extrait sec aqueux | 0.15 g |
| Phellodendron amurense Rupr. | Ecorce | Extrait sec aqueux | 0.15 g |
Additives
E1204
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux personnes sous traitement antidiabétique, sous traitement anticoagulants ou de traitement cardiaque, consultez votre médecin ou pharmacien. Déconseillé aux personnes présentant de troubles hépatiques. Prendre conseil auprès d'un professionnel de la santé si vous suivez un traitement médicamenteux. Déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Regulatory points
- À vérifier
Paeonia spp. (zie ook lijst 3/voir aussi liste 3): dangerous plant prohibited in food in Belgium (list 1). The entire genus Paeonia is listed. List 3 also covers Paeonia x suffruticosa Andrews, parts: racine. Check the plant part used, the preparation, the conditions and the product notification.
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 78 ; liste 3, pages PDF 207.
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Phellodendron amurense Rupr.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- ZHI BAI DI HUANG WAN sinopharma, declared in 2024 : different composition: 2 ingredient(s) added, 2 missing
- Zhi bai di huang wan Laboratoire Calebasse, declared in 2023 : different composition: 0 ingredient(s) added, 1 missing
- Zhi bai di huang wan Calebasse, declared in 2020 : different composition: 2 ingredient(s) added, 2 missing
- Zhi bai di huang wan Calebasse, declared in 2020 : different composition: 2 ingredient(s) added, 3 missing
- Zhi bai di huang wan Calebasse verte, declared in 2019 : different composition: 1 ingredient(s) added, 1 missing
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Zhi bai di huang wan: composition and regulation”, https://compoatlas.com/en/supplements/products/312510-zhi-bai-di-huang-wan, updated 15 November 2026.